Notoginsenoside R2

Cat. No.: 0225LY-1439

Appearance: Solid

Purity: ≥99%

Identity: Confirmed by NMR, and LC-MS.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: Notoginsenoside R2 provides neuroprotection against 6-OHDA toxicity by activating Nrf2 and P90RSK via the MEK1/2-ERK1/2 signaling cascade.

Synonym: 20(S)-Notoginsenoside R2; Ginsenoside Ng-R2; 80418-25-3; (2S,3R,4S,5R)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol; Ginsenoside Ng-R2; (2S,3R,4S,5R)-2-((2R,3R,4S,5S,6R)-2-(((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-((2S)-2-hydroxy-6-methylhept-5-en-2-yl)-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta(a)phenanthren-6-yl)oxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl)oxyoxane-3,4,5-triol

CAS No.: 80418-25-3

Compound CID: 21599925

Formula: C₄₁H₇₀O₁₃

Formula Weight: 770.99

Specification

Relative Density: 1.314 g/cm³

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: Notoginsenoside R2 can be used in cardiovascular research to investigate its role in protecting against oxidative stress and myocardial injury.